Forte Biosciences, Inc. (FBRX) › Capital ExpendituresForte Biosciences, Inc. (FBRX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2015: $231.0K2016: $525.0K2017: $655.0K2018: $1.97M2019: $162.0K2023: $88.0K2024: $37.0K2025: $116.0K$116.0K2015Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$116.0K+213.5%2024$37.0K-58.0%2023$88.0K—2019$162.0K-91.8%2018$1.97M+200.5%2017$655.0K+24.8%2016$525.0K+127.3%2015$231.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share